VEA
NVAX icon

Virtus ETF Advisers’s Novavax NVAX Stock Holding History

Virtus ETF Advisers’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,765
Closed -$312K – 668
2024
Q4 		$312K Buy
38,765
+16,881
+77% +$163K 0.13% 243
2024
Q3 		$276K Hold
21,884
– – 0.13% 235
2024
Q2 		$277K Buy
21,884
+6,656
+44% +$67K 0.14% 236
2024
Q1 		$72.8K Sell
15,228
-1,043
-6% -$4.84K 0.04% 405
2023
Q4 		$78.1K Buy
16,271
+3,458
+27% +$21.2K 0.05% 418
2023
Q3 		$92.8K Sell
12,813
-1,272
-9% -$10.2K 0.06% 344
2023
Q2 		$105K Buy
14,085
+8,212
+140% +$64.6K 0.06% 359
2023
Q1 		$40.7K Sell
5,873
-2,256
-28% -$20.8K 0.02% 436
2022
Q4 		$83.6K Buy
8,129
+5,436
+202% +$95.9K 0.04% 443
2022
Q3 		$49K Buy
2,693
+14
+0.5% +$607 0.02% 434
2022
Q2 		$138K Buy
2,679
+1,758
+191% +$91.1K 0.05% 334
2022
Q1 		$68K Sell
921
-54
-6% -$4.82K 0.03% 355
2021
Q4 		$139K Sell
975
-53
-5% -$9.11K 0.05% 362
2021
Q3 		$213K Sell
1,028
-49
-5% -$10.8K 0.09% 257
2021
Q2 		$229K Sell
1,077
-1,231
-53% -$226K 0.09% 243
2021
Q1 		$418K Buy
2,308
+33
+1% +$6.58K 0.18% 174
2020
Q4 		$254K Sell
2,275
-4,491
-66% -$477K 0.11% 307
2020
Q3 		$733K Sell
6,766
-926
-12% -$113K 0.38% 101
2020
Q2 		$641K Buy
+7,692
New +$294K 0.3% 99
2019
Q1 		– Sell
-6,560
Closed -$241K – 225
2018
Q4 		$241K Sell
6,560
-8,046
-55% -$312K 0.04% 165
2018
Q3 		$549K Sell
14,606
-10,442
-42% -$294K 0.06% 114
2018
Q2 		$671K Sell
25,048
-3,179
-11% -$107K 0.59% 116
2018
Q1 		$1.19M Buy
28,227
+14,967
+113% +$601K 1.03% 20
2017
Q4 		$329K Sell
13,260
-2,154
-14% -$52.6K 0.41% 112
2017
Q3 		$351K Buy
15,414
+1,410
+10% +$31.6K 0.05% 121
2017
Q2 		$322K Buy
14,004
+3,156
+29% +$61.9K 0.05% 103
2017
Q1 		$278K Buy
10,848
+1,040
+11% +$28.6K 0.05% 146
2016
Q4 		$247K Buy
9,808
+7,930
+422% +$231K 0.07% 148
2016
Q3 		$78K Hold
1,878
– – 0.04% 153
2016
Q2 		$273K Buy
1,878
+339
+22% +$38.9K 0.2% 70
2016
Q1 		$159K Sell
1,539
-97
-6% -$10.4K 0.22% 114
2015
Q4 		$274K Buy
+1,636
New +$252K 0.75% 52

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's NVAX Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Novavax (NVAX) in Q1 2025, closing a stake of 38,765 shares — an estimated $312K sold.

Virtus ETF Advisers first reported a position in NVAX in Q4 2015 and held it in 32 quarters. The position peaked at $1.19M in Q1 2018. 245 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 38,765 Novavax shares in Q1 2025, an estimated $312K.
  • Virtus ETF Advisers first reported a position in Novavax in Q4 2015 and held it in 32 quarters.
  • Virtus ETF Advisers's Novavax position peaked at $1.19M in Q1 2018.
  • 245 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.